We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Hasta La VISTA, Pancreatic Cancer!

News   Jan 14, 2019 | Original story from The University of Texas MD Anderson Cancer Center

 
VISTA Checkpoint a Potential Pancreatic Cancer Immunotherapy Target

Image credit: Pixabay

 
 
 

RELATED ARTICLES

New Open-source Solution for the Analysis of High Content Screening Data

News

A new open-source solution for the analysis of high content screening (HCS) data in biomedical research, has been released.

READ MORE

Researchers Observe Drug Target Assembling in Real-time

News

Over one-third of all FDA-approved drugs act on a specific family of proteins called G-protein coupled receptors (GPCRs). Researchers now show when and how different parts of a GPCR interacts with its G protein signaling partners.

READ MORE

New DNA-nanotechnology Enhances DNA and RNA Analysis

News

A research team has now developed "Signal Amplification by Exchange Reaction" (SABER), a highly programmable and practical method that significantly enhances the sensitivity as well as customization and multiplexing capabilities of Fluorescence in situ hybridization analysis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE